Wordt geladen...
Beyond abiraterone: New hormonal therapies for metastatic castration-resistant prostate cancer
Prostate cancer is a heterogeneous disease where the previous concept of “hormone resistance” has been changed by a new generation of hormonal therapies that have proven efficacy in the castration-resistant setting. The fact is that androgens play a crucial role in the whole clinical course of prost...
Bewaard in:
Hoofdauteur: | |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Landes Bioscience
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3928129/ https://ncbi.nlm.nih.gov/pubmed/24100689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.26724 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|